Overexpression of COL5A2 has been detected in patients with gastric, prostatic, and colorectal malignancies, and thus can predict the prognosis of tumor patients (Januchowski et al., 2014; Ren et al., 2021; Tan et al., 2021). The gene discussed is COL5A2; the disease is neoplasm.